IMARC Group, a leading market research company, has recently releases report titled “Synthetic Biology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global synthetic biology market size, growth, share, trends, and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Industry Overview of Synthetic Biology

Synthetic biology refers to an interdisciplinary field of science that combines principles from biology, engineering, and computer science to develop and construct new biological systems or modify existing ones. It aims to create artificial biological components, pathways, and organisms with novel functionalities not found in nature. Synthetic biology involves the engineering of genetic materials, such as deoxyribonucleic acid (DNA), to create biological systems that can perform specific tasks or produce desired products. It also includes designing new genes, pathways, and regulatory elements and modifying existing genetic material to achieve specific outcomes. It can design organisms that detect specific biological markers, which enables rapid diagnostics for diseases. It aids in wastewater treatment by breaking down contaminants and improving water quality. It finds applications in biofuel production, pharmaceutical development, agricultural improvements, and environmental remediation.

How Big Is the Synthetic Biology Market?

The global synthetic biology market size reached US$ 13.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 38.8 Billion by 2028, exhibiting a growth rate (CAGR) of 18.1% during 2023-2028.

Request Sample Copy of This Report: https://www.imarcgroup.com/synthetic-biology-market/requestsample

What are the growth prospects and trends in the synthetic biology industry?

The increasing inclination towards tailor-made therapeutic solutions, such as personalized medicine, gene therapies, and synthetic vaccines, represents one of the primary factors driving the demand for synthetic biology around the world. Moreover, the rising ability to engineer organisms for detection, neutralization, and remediation of biothreats is catalyzing the need for synthetic biology solutions in biodefense and biosecurity applications. In addition, synthetic biology is employed in the agriculture sector to enhance crop yield, nutritional value, and resistance to pests or environmental stresses. Genetic modification can lead to drought-resistant plants or crops that require fewer fertilizers, which promotes sustainable farming and addresses global food security issues.

Along with this, the increasing farming activities and the rising demand for organic food on account of the growing awareness among individuals about the hazardous impact of pesticides are influencing the market positively. Apart from this, the increasing adoption of synthetic biology in the production of biofuels from various feedstocks, including non-food crops or waste that are more sustainable and cleaner alternatives to fossil fuels and offer renewable energy sources, and reduce greenhouse gas emissions is bolstering the market growth. Furthermore, synthetic biology finds application in the food and beverage (FB) sector for manufacturing different food ingredients for the vegan population.

This, coupled with the rising adoption of vegan and vegetarian diets among the masses on account of its numerous advantages, is favoring the growth of the market. Besides this, the growing usage of synthetic biology for producing sustainable and ethical cosmetic ingredients, like bioengineered collagen or hyaluronic acid, that ensures consistent quality, reduces dependence on animal sources and caters to environmental conscious consumers is creating a positive outlook for the market.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Product:

• Oligonucleotide/Oligo Pools and Synthetic DNA
• Enzymes
• Cloning Technologies Kits
• Xeno-nucleic Acids
• Chassis Organism

Breakup by Technology:

• NGS Technology
• PCR Technology
• Genome Editing Technology
• Bioprocessing Technology
• Others

Breakup by Application:

• Healthcare
  • Clinical
  • Non-Clinical/Research
• Non-Healthcare
  • Biotech Crops
  • Specialty Chemicals
  • Bio-Fuels

Others

Breakup by Region:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

• Agilent Technologies Inc.
• Amyris Inc.
• Codexis Inc.
• Danaher Corporation
• Eurofins Scientific
• GenScript Biotech Corporation
• Illumina Inc.
• Merck KGaA
• New England Biolabs
• Synthego Corporation
• Thermo Fisher Scientific Inc.
• Twist Bioscience
• Viridos Inc.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: [email protected]

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/